Nuzenio

Zentalis Pharmaceuticals

Zentalis Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 9 publisher sources 100/100 entity strength

Latest news

ZNTL Stock Rallies To Near 22-Month Highs – An Analyst Sees Further 56% Upside After A Crucial Trial Update - StocktwitsStocktwits · Sat, 08 Aug 2026 06:32:17 GMTZentalis Pharmaceuticals (NASDAQ:ZNTL) Cut to Strong Sell at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:18:56 GMTWedbush Adjusts Price Target on Zentalis Pharmaceuticals to $5 From $4, Maintains Neutral Rating - MoomooMoomoo · Fri, 07 Aug 2026 20:53:39 GMTZentalis Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $7.44, Implies 49% Upside - TradingViewTradingView · Fri, 07 Aug 2026 17:20:35 GMTMorgan Stanley Adjusts PT on Zentalis Pharmaceuticals to $5 From $4, Maintains Equalweight Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 09:32:24 GMTZNTL Advances Clinical Trials for Ovarian Cancer Drug Amid Valua - GuruFocusGuruFocus · Thu, 06 Aug 2026 23:38:12 GMTZentalis Pharmaceuticals, Inc. 2Q 2026: Net loss $(42.3M), EPS $(0.59) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:36:00 GMTZentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:05:00 GMT

Timeline

Sat, 08 Aug 2026 06:32:17 GMTZNTL Stock Rallies To Near 22-Month Highs – An Analyst Sees Further 56% Upside After A Crucial Trial Update - Stocktwits
Sat, 08 Aug 2026 05:18:56 GMTZentalis Pharmaceuticals (NASDAQ:ZNTL) Cut to Strong Sell at Wall Street Zen - MarketBeat
Fri, 07 Aug 2026 20:53:39 GMTWedbush Adjusts Price Target on Zentalis Pharmaceuticals to $5 From $4, Maintains Neutral Rating - Moomoo
Fri, 07 Aug 2026 17:20:35 GMTZentalis Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $7.44, Implies 49% Upside - TradingView
Fri, 07 Aug 2026 09:32:24 GMTMorgan Stanley Adjusts PT on Zentalis Pharmaceuticals to $5 From $4, Maintains Equalweight Rating - marketscreener.com
Thu, 06 Aug 2026 23:38:12 GMTZNTL Advances Clinical Trials for Ovarian Cancer Drug Amid Valua - GuruFocus

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Zentalis Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.